TY - JOUR
T1 - Treatment of resistant hypertension
AU - Taler, Sandra J.
PY - 2005/10
Y1 - 2005/10
N2 - Although the true prevalence of resistant hypertension is not known, it is likely that this condition will become increasingly common, driven by an aging population, obesity, nonadherence trends, and effects of target-organ disease. Current approaches focus on two goals: evaluation and correction of contributing causes, then selection of an effective drug regimen. Lifestyle factors contribute to resistance, particularly high sodium intake and weight gain. Secondary causes should be considered and corrected if feasible. Recent efforts have focused on the development of clinical pathways to guide treatment, based on plasma renin activity, aldosterone production, or hemodynamic measurements. The components of drug combinations beyond the second agent remain empiric. Although volume expansion plays a key role in drug resistance, clinical assessment of volume status is often difficult, frustrating efforts to achieve blood pressure control. Determination of the most effecidve approaches will require clinical trials using combination therapy.
AB - Although the true prevalence of resistant hypertension is not known, it is likely that this condition will become increasingly common, driven by an aging population, obesity, nonadherence trends, and effects of target-organ disease. Current approaches focus on two goals: evaluation and correction of contributing causes, then selection of an effective drug regimen. Lifestyle factors contribute to resistance, particularly high sodium intake and weight gain. Secondary causes should be considered and corrected if feasible. Recent efforts have focused on the development of clinical pathways to guide treatment, based on plasma renin activity, aldosterone production, or hemodynamic measurements. The components of drug combinations beyond the second agent remain empiric. Although volume expansion plays a key role in drug resistance, clinical assessment of volume status is often difficult, frustrating efforts to achieve blood pressure control. Determination of the most effecidve approaches will require clinical trials using combination therapy.
UR - http://www.scopus.com/inward/record.url?scp=27544498604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27544498604&partnerID=8YFLogxK
U2 - 10.1007/s11906-005-0064-6
DO - 10.1007/s11906-005-0064-6
M3 - Review article
C2 - 16157072
AN - SCOPUS:27544498604
SN - 1522-6417
VL - 7
SP - 323
EP - 329
JO - Current Hypertension Reports
JF - Current Hypertension Reports
IS - 5
ER -